D

    Delcath Systems Inc (DCTH)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $16.46
    +0.12 (+0.73%)

    Market Cap: $571.14M

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    70%(19/27)
    Avg Surprise
    -23.62%
    Streak
    6 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.07
    Range$-0.13 - $-0.01
    4 analysts
    EPS RevisionsNo revisions (7d)
    0
    3
    30d
    EPS Estimate Drift
    90d ago$-0.22-208.6%
    60d ago$-0.22-208.6%
    30d ago$-0.21-196.4%
    7d ago$-0.21-196.4%
    Current$-0.07
    Revenue Consensus
    $26M
    Range$25M - $27M
    5 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.13
    Range$0.05 - $0.26
    4 analysts
    Revenue Consensus
    $28M
    Range$27M - $30M
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.13---
    Sep 26EST
    		-$-0.07---
    Jun 26
    Reported Aug 6
    		$0.07N/A+143.75%Beat+0.0%
    Mar 26
    Reported May 7
    		$-0.03N/A+66.67%Beat-200.0%
    Dec 25
    Reported Feb 26
    		$-0.05$-0.06+16.67%Beat+54.5%
    Sep 25
    Reported Nov 4
    		$0.02N/A+122.22%Beat-66.7%
    Jun 25
    Reported Aug 6
    		$0.07$0.03+133.33%Beat+114.6%
    Mar 25
    Reported May 8
    		$0.03$0.03+15.38%Beat+106.7%
    Dec 24
    Reported Mar 6
    		$-0.11$0.01-1200.00%Miss+77.1%
    Sep 24
    Reported Nov 8
    		$0.06N/A+131.58%Beat+105.3%
    Jun 24
    Reported Aug 5
    		$-0.48$-0.34-41.18%Miss+17.2%
    Mar 24
    Reported May 14
    		$-0.45$-0.45+0.00%Beat+41.6%
    Dec 23
    Reported Mar 26
    		$-0.48$-0.51+5.88%Beat+44.2%
    Sep 23
    Reported Nov 13
    		$-1.14$-0.49-132.65%Miss-23.9%
    Jun 23
    Reported Aug 9
    		$-0.58$-0.66+12.12%Beat+50.8%
    Mar 23
    Reported May 22
    		$-0.77$-0.62-24.19%Miss+23.0%
    Dec 22
    Reported Mar 27
    		$-0.86$-0.73-17.81%Miss-24.6%
    Sep 22
    Reported Nov 8
    		$-0.92$-1.04+11.54%Beat+2.1%
    Jun 22
    Reported Aug 8
    		$-1.18$-1.01-16.83%Miss-22.9%
    Mar 22
    Reported May 10
    		$-1.00$-0.86-16.28%Miss+3.8%
    Dec 21
    Reported Mar 25
    		$-0.69$-1.01+31.68%Beat-15.0%
    Sep 21
    Reported Nov 9
    		$-0.94$-1.13+16.81%Beat+19.0%
    Jun 21
    Reported Aug 10
    		$-0.96$-1.06+9.43%Beat+49.5%
    Mar 21
    Reported May 11
    		$-1.04$-1.03-0.97%Miss+99.0%
    Dec 20
    Reported Mar 31
    		$-0.60$-1.09+44.95%Beat-100.2%
    Sep 20
    Reported Nov 11
    		$-1.16$-2.11+45.02%Beat-182.9%
    Jun 20
    Reported Aug 13
    		$-1.90$-2.00+5.00%Beat-2275.0%
    Mar 20
    Reported May 14
    		$-108.07$-108.07+0.00%Beat-98145.5%
    Dec 19
    Reported Mar 25
    		$269.30N/AN/ABeat+158511.8%
    Sep 19
    Reported Nov 14
    		$-0.41N/AN/ABeat-64.0%
    Jun 19
    Reported Jul 17
    		$-0.08N/AN/ABeat+98.9%
    Mar 19
    Reported Jun 14
    		$-0.11N/AN/ABeat-101.0%
    Dec 18
    Reported Mar 13
    		$-0.17N/AN/ABeat+100.0%
    Sep 18
    Reported Nov 13
    		$-0.25N/AN/ABeat+100.0%
    Jun 18
    Reported Aug 15
    		$-7.26N/AN/ABeat+99.5%
    Mar 18
    Reported May 10
    		$10.91N/AN/ABeat+100.0%
    Dec 17
    Reported Mar 16
    		$-380.17N/AN/ABeat+100.0%
    Sep 17
    Reported Nov 14
    		$-4493.76N/AN/ABeat+99.6%
    Jun 17
    Reported Aug 8
    		$-1347.43N/AN/ABeat-
    Mar 17
    Reported May 9
    		$-43922.48N/AN/ABeat-
    Dec 16
    Reported Mar 29
    		$-1000000.00N/AN/ABeat-
    Sep 16
    Reported Nov 11
    		$-1000000.00$-1000000.00+0.00%Beat-

    Key Metrics

    Valuation
    P/E Ratio1646.00EV/EBITDA294.18x
    Price/FCF33.75xFCF Yield2.96%
    Profitability
    Profit Margin0.56%Operating Margin8.22%
    ROE0.47%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio9.83xQuick Ratio8.95x
    Trading Statistics
    Beta0.52Avg Volume738.54K
    52-Week High$17.4252-Week Low$8.12

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$16.72
    SMA 20$16.28
    SMA 50$14.10
    SMA 200$11.11
    EMA 10$16.50
    EMA 20$15.98
    EMA 50$14.47
    EMA 200$12.14

    MACD

    Line: 0.81Signal: 0.99Hist: -0.17

    ADX

    ADX: 34.4+DI: 23.4-DI: 16.3

    Aroon & PSAR

    Aroon Up44.0
    Aroon Down8.0
    PSAR$17.28

    Bollinger Bands

    Upper Band$18.86
    Lower Band$13.70
    %B Position3170%(Upper)
    Band Width0.53

    RSI (14-Day)

    Neutral
    59.7

    Momentum Oscillators

    Stoch %K33.4
    Stoch %D48.0
    Williams %R-72.3
    ROC (10d)-3.5%
    Momentum-0.59
    CCI (20d)7.9
    MFI (14d)45.7

    Volatility Measures

    ATR (14d)$0.61(3.7%)
    StdDev (20d)1.29
    Hist Vol93.6%(High)

    Volume Flow

    VWAP$16.35
    OBV-9.1M
    AD Line-9.8M
    CMF (20d)0.296

    Volume Metrics

    Avg Vol (20d)746.5K
    Vol Ratio0.5x
    VWMA (20d)$16.22

    Pivot Points

    R3$16.84
    R2$16.67
    R1$16.50
    Pivot Point$16.33
    S1$16.16
    S2$15.99
    S3$15.82

    Advanced Oscillators

    TSI28.20
    Ultimate Osc53.4
    KST288.70

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$29.13M$24.99M$20.73M$20.56M$24.16M$19.78M$15.10M$11.20M$7.77M$3.14M$539,000$434,000
    Cost of Revenue$2.98M$3.74M$3.01M$2.62M$3.32M$2.85M$2.13M$1.64M$1.52M$903,000$171,000$133,000
    Gross Profit$26.15M$21.26M$17.72M$17.94M$20.84M$16.94M$12.97M$9.56M$6.25M$2.24M$368,000$301,000
    Operating Expenses$23.75M$22.89M$19.90M$18.33M$18.25M$16.30M$9.94M$10.82M$10.16M$12.51M$11.67M$10.86M
    R&D$10.38M$9.82M$9.37M$7.99M$6.88M$5.01M$2.91M$3.87M$3.39M$3.70M$4.71M$4.66M
    SG&A$13.37M$13.07M$10.53M$10.34M$11.37M$11.29M$7.02M$6.95M$6.76M$8.81M$6.96M$6.20M
    Operating Income$2.40M$-1,637,000$-2,184,000$-388,000$2.59M$642,000$3.04M$-1,259,000$-3,912,000$-10,278,000$-11,304,000$-10,556,000
    Interest Income$781,000$787,000$857,000$796,000$649,000$618,000$295,000$113,000$-84,000$-199,000$15,000$-395,000
    Interest Expense$0$0$0$0$0$0$6.44M$0$9.83M$833,000$0$9.78M
    Income Before Tax$3.16M$-908,000$-1,334,000$375,000$3.21M$1.26M$-3,398,000$1.86M$-13,741,000$-11,111,000$-11,063,000$-20,335,000
    Income Tax Expense$491,000$162,000$562,000$-455,000$508,000$195,000$0$0$0$0$0$0
    Net Income$2.67M$-1,070,000$-1,896,000$830,000$2.70M$1.07M$-3,398,000$1.86M$-13,741,000$-11,111,000$-11,136,000$-20,340,000
    EBITDA$2.11M$-2,004,000$-2,536,000$-802,000$2.18M$407,000$-3,773,000$1.75M$-13,574,000$-10,816,000$-10,723,000$-19,718,000
    EBIT$2.38M$-1,695,000$-2,187,000$-421,000$2.56M$646,000$-3,705,000$1.75M$-13,667,000$-10,890,000$-11,078,000$-19,940,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about DCTH

    News

    Liquidity Mapping Around (DCTH) Price Events

    This article provides a liquidity mapping analysis for Delcath Systems Inc. (DCTH), indicating strong sentiment across all horizons and compelling upside potential. It details AI-generated institutional trading strategies for various risk profiles, including position, momentum breakout, and risk hedging strategies, along with multi-timeframe signal analysis for support and resistance levels.

    Stock Traders Daily•8/15/26•
    Bullish

    Delcath Systems updates bylaws to designate Delaware courts as exclusive forum

    Delcath Systems (NASDAQ:DCTH) has amended its bylaws to designate Delaware courts as the exclusive forum for internal corporate claims and federal district courts for claims under the Securities Act of 1933. This decision, effective immediately, follows a recommendation from the Nominating and Corporate Governance Committee. The company also reported strong second-quarter 2026 revenues of $29.1 million, driven by demand for its HEPZATO KIT, and raised its full-year revenue guidance.

    Investing.com•8/14/26•
    Somewhat-Bullish

    Delcath Systems updates bylaws to designate Delaware courts as exclusive forum

    Delcath Systems, Inc. (NASDAQ:DCTH) has amended its bylaws to designate Delaware courts as the exclusive forum for internal corporate claims and federal district courts for claims under the Securities Act of 1933. This decision follows a recommendation from its Nominating and Corporate Governance Committee. The company also recently reported strong Q2 2026 revenues of $29.1 million, exceeding forecasts, driven by demand for its HEPZATO KIT, and raised its full-year revenue guidance.

    Investing.com•8/14/26•
    Bullish

    Form 8K Delcath Systems Inc For: 14 August By Investing.com

    This article announces the filing of a Form 8K by Delcath Systems Inc. on August 14th. It is a brief news item from Investing.com, providing basic information about the regulatory filing.

    Investing.com Canada•8/14/26•
    Bearish

    Delcath Systems (DCTH) adopts new exclusive forum clauses in amended bylaws

    Delcath Systems, Inc. (DCTH) has amended its bylaws, effective August 12, 2026, to include exclusive forum provisions for legal disputes. The updated bylaws designate the Court of Chancery of the State of Delaware as the exclusive forum for internal corporate claims, and the federal district courts of the United States as the exclusive forum for claims under the Securities Act of 1933, unless the company provides written consent for an alternative forum. This change aims to centralize where certain corporate legal actions can be brought against the company.

    Stock Titan•8/14/26•
    Neutral

    Frequently Asked Questions About DCTH

    Does DCTH pay dividends?
    Delcath Systems Inc (DCTH) does not currently pay a regular dividend.
    What is DCTH's P/E ratio?
    Delcath Systems Inc has a price-to-earnings (P/E) ratio of 1646.00.
    What is DCTH's market cap?
    Delcath Systems Inc (DCTH) has a market capitalization of $571.14M with a current stock price of $16.46.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In